This is to acknowledge that on March 27, 2019, the Market Regulation Department of the Financial Industry Regulatory Authority (FINRA) received the complaint you sent regarding trading activity in Innovation Pharmaceuticals Inc. (“IPIX”). We will use the information you have provided regarding IPIX in the scope of the regulatory programs we conduct. Please note that the reviews conducted by the Market Regulation Department are confidential and non-public. FINRA staff may, however, contact you for additional information about your complaint.



If you have any questions, please contact Market Regulation Customer Complaints at (240) 386-5105, or through E-Mail at MarketRegComplaints@finra.org